SCI Pharmtech, Inc.

City:

Country:

Taiwan

Published Applications:

Last publication date:

2014-01-02

Patent Grants:

Last grant date:

2015-02-17

Top Inventors for applications by SCI Pharmtech, Inc.

These are the the leading inventors for applications assigned to SCI Pharmtech, Inc.:

Jinun-Ban Yeh 3 Taoyuan, Taiwan
Wei-Chyun Wong 3 Taoyuan, Taiwan
Bo-Fong Chen 3 Taoyuan, Taiwan
Feng-Ju Lu 2 Taoyuan, Taiwan

Jinun-Ban Yeh 2 Hsinchu, Taiwan
Wei-chyun Wong 2 Hsinchu, Taiwan
Bo-Fong Chen 1 Hsinchu, Taiwan
Wei-chyun Wong 1 Taipei, Taiwan

Yeh-Chi Su 1 Taoyuan, Taiwan
Feng-hsu Li 1 Taoyuan, Taiwan
Jen-Huang Kuo 1 Hsinchu, Taiwan
Yen-Wei Li 1 Taoyuan, Taiwan

Yan-Wei Li 1 Hsinchu, Taiwan
Bo-Fong Chen 1 Taichung, Taiwan

Recent patent applications by SCI Pharmtech, Inc.

SCI Pharmtech, Inc. based in , TW has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-01-02 ✅ Patent 8,957,227 granted on 2015-02-17

US20140005414A1

Chemistry; metallurgy

Preparation of Duloxetine® hydrochloride using optically active methylhydroxylaminopropanol compound as an intermediate

#2 | 2012-02-02 ✅ Patent 8,273,917 granted on 2012-09-25

US20120029230A1

Chemistry; metallurgy

Method for preparing chiral baclofen

#3 | 2011-12-29 ✅ Patent 8,299,305 granted on 2012-10-30

US20110319664A1

Chemistry; metallurgy

Method for preparing atomoxetine

#4 | 2011-11-10 ✅ Patent 8,530,674 granted on 2013-09-10

US20110275835A1

Chemistry; metallurgy

Process for preparing ()-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine by using optically active methylhydroxylaminopropanol compound as intermediate

#5 | 2010-09-16 ✅ Patent 8,614,336 granted on 2013-12-24

US20100234620A1

Chemistry; metallurgy

Process for preparing -methyl--hydroxyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine derivative

#6 | 2010-09-16 ✅ Patent 8,148,549 granted on 2012-04-03

US20100234619A1

Chemistry; metallurgy

Preparation of (S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl) propylamine using optically active methylhydroxylaminopropanol compound as an intermediate

AssigneeID:

450585 ⎘